GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » Cash Ratio

Syra Health (Syra Health) Cash Ratio : 2.94 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Syra Health Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Syra Health's Cash Ratio for the quarter that ended in Mar. 2024 was 2.94.

Syra Health has a Cash Ratio of 2.94. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Syra Health's Cash Ratio or its related term are showing as below:

SYRA' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.39   Max: 3.6
Current: 2.94

During the past 4 years, Syra Health's highest Cash Ratio was 3.60. The lowest was 0.01. And the median was 0.39.

SYRA's Cash Ratio is ranked better than
86.92% of 650 companies
in the Healthcare Providers & Services industry
Industry Median: 0.485 vs SYRA: 2.94

Syra Health Cash Ratio Historical Data

The historical data trend for Syra Health's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syra Health Cash Ratio Chart

Syra Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash Ratio
0.43 0.22 - 3.60

Syra Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.55 0.03 0.01 3.60 2.94

Competitive Comparison of Syra Health's Cash Ratio

For the Medical Care Facilities subindustry, Syra Health's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syra Health's Cash Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Syra Health's Cash Ratio falls into.



Syra Health Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Syra Health's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=3.28/0.91
=3.60

Syra Health's Cash Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash Ratio (Q: Mar. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=3.238/1.102
=2.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syra Health  (NAS:SYRA) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Syra Health Cash Ratio Related Terms

Thank you for viewing the detailed overview of Syra Health's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Syra Health (Syra Health) Business Description

Traded in Other Exchanges
N/A
Address
1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.
Executives
Sandeep Allam director, officer: President and Chair 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed 10 percent owner 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi director, officer: Chief Executive Officer 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers director 1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas 10 percent owner 2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc 10 percent owner 6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad officer: CFO and COO 1119 KEYSTONE WAY N., #201, CARMEL IN 46032